Antidote Health Seed

Funding π°
Total $13M
Last round π August 25, 2021.
Select investors iAngels, Well-Tech Ventures, Flint Capital
Key people π§βπ€βπ§
- Avihai Soudri - Co-founder & CEO
- Carine-Belle Feder - Co-founder & CTO
- David Zlotnick MDCM CCFP-EM - Co-founder & Chief Medical Officer
- Marc Kenigsberg - CMO
- Ortal Halperin Eilon - Head of Finance
Highlights β
- Telehealth use has been growing during the COVID-19 pandemic and now represents a quarter-trillion dollar economic opportunity, according to McKinsey & Company. π
- Antidote's membership business model is good for cashflow.
- This [technology] expertise and ability to simplify processes coupled with Fintech advances that allow for payment from the palm of your hands has made way for Antidote Health's solution to an age-old issue. - Shelly Hod Moyal, iAngels Founding Partner. π
- Antidote's CEO Avihai Soudri previously led the innovation and business development at Leumit and served as CEO of health insurance company Vectis, which was acquired by Swiss-Re in 2019. The company's CTO and Chief Medical Officer are also experienced executives.
Last update: September 6, 2021
Disclaimer: We can not guarantee that the information on this page is 100% correct. more